| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Anti‐glycoprotein VI mediated immune thrombocytopenia: An under‐recognized and significant entity?
|
Rabbolini, David J.
|
|
|
1 |
2 |
p. 291-295
|
artikel
|
| 2 |
Assessment of the effect of direct oral anticoagulants dabigatran, rivaroxaban, and apixaban in healthy male volunteers using a thrombin generation assay
|
Artang, Ramin
|
|
|
1 |
2 |
p. 194-201
|
artikel
|
| 3 |
Clinical outcomes during anticoagulant therapy in fragile patients with venous thromboembolism
|
Moustafa, Farès
|
|
|
1 |
2 |
p. 172-179
|
artikel
|
| 4 |
Clot stability as a determinant of effective factor VIII replacement in hemophilia A
|
Leong, Lilley
|
|
|
1 |
2 |
p. 231-241
|
artikel
|
| 5 |
Defects of splicing in antithrombin deficiency
|
de la Morena‐Barrio, María E.
|
|
|
1 |
2 |
p. 216-222
|
artikel
|
| 6 |
Galectin‐3 and venous thromboembolism incidence: the Atherosclerosis Risk in Communities (ARIC) Study
|
Fashanu, Oluwaseun E.
|
|
|
1 |
2 |
p. 223-230
|
artikel
|
| 7 |
Identification of deep intronic individual variants in patients with hemophilia A by next‐generation sequencing of the whole factor VIII gene
|
Inaba, Hiroshi
|
|
|
1 |
2 |
p. 264-274
|
artikel
|
| 8 |
Indexing for a new journal: Research and Practice in Thrombosis and Haemostasis
|
Cushman, Mary
|
|
|
1 |
2 |
p. 148-149
|
artikel
|
| 9 |
ISSUE INFORMATION
|
|
|
|
1 |
2 |
p. 143-147
|
artikel
|
| 10 |
Near‐patient coagulation testing to predict bleeding after cardiac surgery: a cohort study
|
Mumford, Andrew D.
|
|
|
1 |
2 |
p. 242-251
|
artikel
|
| 11 |
Neurosurgery in a patient at peak levels of rivaroxaban: taking into account all factors
|
De Vlieger, Jan
|
|
|
1 |
2 |
p. 296-300
|
artikel
|
| 12 |
Pathogenesis, prevention, and management of bleeding and thrombosis in patients with liver diseases
|
Lisman, Ton
|
|
|
1 |
2 |
p. 150-161
|
artikel
|
| 13 |
Preclinical evaluation of point‐of‐care prothrombin time as a biomarker test to guide prothrombin replacement therapy in coagulopathic bleeding
|
Balendran, Clare A.
|
|
|
1 |
2 |
p. 252-258
|
artikel
|
| 14 |
Principles and theory guiding development and delivery of patient education in disorders of thrombosis and hemostasis: Reviewing the current literature
|
Hews‐Girard, Julia
|
|
|
1 |
2 |
p. 162-171
|
artikel
|
| 15 |
Reduced dosing of enoxaparin for venous thromboembolism in overweight and obese adolescents: a single institution retrospective review
|
Hoffman, Stephanie
|
|
|
1 |
2 |
p. 188-193
|
artikel
|
| 16 |
Safety, pharmacokinetics and pharmacodynamics of idarucizumab, a specific dabigatran reversal agent in healthy Japanese volunteers: a randomized study
|
Yasaka, Masahiro
|
|
|
1 |
2 |
p. 202-215
|
artikel
|
| 17 |
Structural origins of hemostasis and adaptive immunity
|
Ware, Jerry
|
|
|
1 |
2 |
p. 286-290
|
artikel
|
| 18 |
The impact of body weight on rivaroxaban pharmacokinetics
|
Barsam, Sarah J.
|
|
|
1 |
2 |
p. 180-187
|
artikel
|
| 19 |
Thromboelastography does not predict outcome in different etiologies of cirrhosis
|
Hugenholtz, Greg C.G.
|
|
|
1 |
2 |
p. 275-285
|
artikel
|
| 20 |
Underestimation of N‐glycoPEGylated factor IX one‐stage clotting activity owing to contact activator‐impaired activation
|
Persson, Egon
|
|
|
1 |
2 |
p. 259-263
|
artikel
|
Tijdschrift beschrijving